N/A
N=11,234
Evaluation of a Letter Intervention Promoting a Plant-based Diet
Cardiovascular Diseases · Diabetes Mellitus · Obesity
Bottom Line
View on ClinicalTrials.gov: NCT03880838 ↗Enrolled (actual)
11,234
Serious AEs
—
Results posted
Sep 2023
Primary outcome: Primary: Medical Cost in US Dollars From One Year Before to One Year After Intervention — 6123.39; 5863.82; 5901.99; 5630.26 dollars
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Personal testimonial (Behavioral); Forks Over Knives Documentary (Behavioral); Commitment nudge (Behavioral); Prevention nudge (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Geisinger Clinic
- Primary completion
- Jun 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Medical Cost in US Dollars From One Year Before to One Year After Intervention |
6123.39; 5863.82; 5901.99; 5630.26; 6427.50; 6343.24 | — |
| PRIMARY Number of Visits From One Year Before to One Year After Intervention |
5.59; 5.57; 5.17; 5.66; 5.69; 5.77 | — |
| PRIMARY Number of Prescriptions From One Year Before to One Year After Intervention |
48.96; 48.02; 47.44; 50.85; 50.50; 49.66 | — |
| PRIMARY Number of Unique Prescribed Medication From One Year Before to One Year After Intervention |
8.12; 8.15; 7.90; 8.50; 8.47; 8.48 | — |
| PRIMARY Body Mass Index From One Year Before to One Year After Intervention |
36.44; 36.48; 36.46; 36.20; 37.26; 36.58 | .391 |
| PRIMARY Systolic Blood Pressure From One Year Before to One Year After Intervention |
130.00; 129.88; 130.47; 131.4; 130.72; 129.27 | .436 |
| PRIMARY Diastolic Blood Pressure From One Year Before to One Year After Intervention |
72.91; 72.79; 72.95; 73.48; 72.93; 72.27 | .357 |
| SECONDARY Triglyceride Levels From One Year Before to One Year After Intervention |
— | — |
| SECONDARY Low-density Lipoprotein (LDL) Levels From One Year Before to One Year After Intervention |
— | — |
| SECONDARY Five Years Before to Two Years After Intervention in Depressed Mood and Anhedonia as Assessed by the Patient Health Questionnaire-2 (PHQ-2) (Extended Time Frame) |
— | — |
| SECONDARY Hemoglobin A1c (hbA1c) From Five Years Before to Two Years After Intervention (Extended Time Frame) |
— | — |
| SECONDARY Low-density Lipoprotein/High-density Lipoprotein (LDL/HDL) Ratios From Five Years Before to Two Years After Intervention (Extended Time Frame) |
— | — |
| SECONDARY High-density Lipoprotein (HDL) Levels From Five Years Before to Two Years After Intervention (Extended Time Frame) |
— | — |
| SECONDARY Low-density Lipoprotein (LDL) Levels From Five Years Before to Two Years After Intervention (Extended Time Frame) |
— | — |
| SECONDARY Triglyceride Levels From Five Years Before to Two Years After Intervention (Extended Time Frame) |
— | — |
| SECONDARY Diastolic Blood Pressure From Five Years Before to Two Years After Intervention (Extended Time Frame) |
— | — |
| SECONDARY Systolic Blood Pressure From Five Years Before to Two Years After Intervention (Extended Time Frame) |
— | — |
| SECONDARY Body Mass Index From Five Years Before to Two Years After Intervention (Extended Time Frame) |
— | — |
| SECONDARY Number of Unique Prescribed Medication From Five Years Before to Two Years After Intervention (Extended Time Frame) |
— | — |
| SECONDARY Number of Prescriptions From Five Years Before to Two Years After Intervention (Extended Time Frame) |
— | — |
| SECONDARY Number of Visits From Five Years Before to Two Years After Intervention (Extended Time Frame) |
— | — |
| SECONDARY Medical Cost in US Dollars From Five Years Before to Two Years After Intervention (Extended Time Frame) |
— | — |
| SECONDARY Values From One Year Before to One Year After Intervention of Depressed Mood and Anhedonia as Assessed by the Patient Health Questionnaire-2 (PHQ-2) |
— | — |
| SECONDARY Hemoglobin A1c (hbA1c) From One Year Before to One Year After Intervention |
— | — |
| SECONDARY Low-density Lipoprotein/High-density Lipoprotein (LDL/HDL) Ratios From One Year Before to One Year After Intervention |
— | — |
| SECONDARY High-density Lipoprotein (HDL) Levels From One Year Before to One Year After Intervention |
— | — |
Summary
The researchers' mission is to promote healthier eating behavior and to reduce costs associated with healthcare. The purpose of this study is to evaluate the effects of mailing randomly selected participants a letter promoting a plant-based diet. Depending on the experimental condition, participants may additionally receive a free documentary, Forks Over Knives, and they may also get letters which use commitment- or prevention-focused messages to encourage watching the documentary and changing their eating behavior. The researchers hypothesize that receiving the documentary will be associated with lower insurance claims and improved health outcomes one and two years later. The researchers also hypothesize that using either commitment- or prevention-focused messages will also contribute to lower insurance claims and improved health outcomes compared to experimental conditions where materials did not include these messages. This study will help the researchers design evidence-supported programs that can improve people's health.
Eligibility Criteria
Inclusion Criteria
- Has two out of the three following conditions:
- Body mass index over 30
- Diagnosis of type 2 diabetes (specifically with at least one medication)
- Diagnosis of cardiovascular disease
- Has health insurance through Geisinger Health Plan (is an active member with a full 12-month enrollment in the previous year) under one of the following categories:
- Medicare with required primary care provider
- Medicaid
- Individual policy under the Affordable Care Act
- Has visited their primary care provider in the past 12 months
Exclusion Criteria
- Is institutionalized
- Has active cancer, cirrhosis, renal failure, dementia, or active psychosis
- Is in the same household as another selected participant
Data sourced from ClinicalTrials.gov (NCT03880838). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.